Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Cytokines in rheumatoid arthritis - shaping the immunological landscape.
McInnes IB, Buckley CD, Isaacs JD. McInnes IB, et al. Nat Rev Rheumatol. 2016 Jan;12(1):63-8. doi: 10.1038/nrrheum.2015.171. Epub 2015 Dec 10. Nat Rev Rheumatol. 2016. PMID: 26656659 Review.
Cytokine-mediated pathways are central to the pathogenesis of rheumatoid arthritis (RA). ...The success of cytokine inhibition in the clinic is also considerable, not only in offering remarkable therapeutic advances, but also in defining the hierarchic
Cytokine-mediated pathways are central to the pathogenesis of rheumatoid arthritis (RA). ...The success of cytokine
Restored and Enhanced Memory T Cell Immunity in Rheumatoid Arthritis After TNFalpha Blocker Treatment.
Khanniche A, Zhou L, Jiang B, Song J, Jin Y, Yin J, Wang S, Ji P, Shen H, Wang Y, Xu H. Khanniche A, et al. Front Immunol. 2019 Apr 24;10:887. doi: 10.3389/fimmu.2019.00887. eCollection 2019. Front Immunol. 2019. PMID: 31105703 Free PMC article.
TNFalpha inhibitors have shaped the landscape of rheumatoid arthritis (RA) therapy with high clinical efficiency. ...We aimed to analyze the immune profiles of memory T cells in RA patients undergoing TNFalpha inhibitor Golimumab (GM) treatment. Freque …
TNFalpha inhibitors have shaped the landscape of rheumatoid arthritis (RA) therapy with high clinical efficiency …
Feedback